Fangchinoline Inhibits Human Esophageal Cancer by Transactivating ATF4 to Trigger Both Noxa-Dependent Intrinsic and DR5-Dependent Extrinsic Apoptosis.
Fangchinoline Inhibits Human Esophageal Cancer by Transactivating ATF4 to Trigger Both Noxa-Dependent Intrinsic and DR5-Dependent Extrinsic Apoptosis.
复制标题
Fangchinoline 通过反式激活 ATF4 触发 Noxa 依赖性内源性和 DR5 依赖性外源性细胞凋亡来抑制人食管癌
DOI:
10.3389/fonc.2021.666549
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Jia L
中科院分区:
文献类型:
--
作者:
Zhang Y;Wang S;Chen Y;Zhang J;Yang J;Xian J;Li L;Zhao H;Hoffman RM;Zhang Y;Jia L
Esophageal squamous cell carcinoma (ESCC) is a recalcitrant cancer. The Chinese herbal monomer fangchinoline (FCL) has been reported to have anti-tumor activity in several human cancer cell types. However, the therapeutic efficacy and underlying mechanism on ESCC remain to be elucidated. In the present study, for the first time, we demonstrated that FCL significantly suppressed the growth of ESCC both in vitro and in vivo. Mechanistic studies revealed that FCL-induced G1 phase cell-cycle arrest in ESCC which is dependent on p21 and p27. Moreover, we found that FCL coordinatively triggered Noxa-dependent intrinsic apoptosis and DR5-dependent extrinsic apoptosis by transactivating ATF4, which is a novel mechanism. Our findings elucidated the tumor-suppressive efficacy and mechanisms of FCL and demonstrated FCL is a potential anti-ESCC agent.
登录
查看更多内容
DOI:
10.1074/jbc.m109.014092
发表时间:
2010-02-26
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Armstrong JL;Flockhart R;Veal GJ;Lovat PE;Redfern CP
通讯作者:
Redfern CP
影响因子:
21.3
作者:
通讯作者:
--
影响因子:
5.4
作者:
Li X;Yang Z;Han W;Lu X;Jin S;Yang W;Li J;He W;Qian Y
通讯作者:
Qian Y
影响因子:
3.8
作者:
Lee, Hyo-Seon;Safe, Stephen;Lee, Syng-Ook
通讯作者:
Lee, Syng-Ook
DOI:
10.3109/14756360902932792
发表时间:
2010-02-01
影响因子:
5.6
作者:
Gulcin, Ilhami;Elias, Riad;Topal, Fevzi
通讯作者:
Topal, Fevzi